Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 07/31/17
End: 01/25/19
Due: 01/25/20
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 03/22/19
Due: 03/22/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System | NCT01184456 | AIDS Healthcare Foundation | user2@example.com | None | 2010-08-31 | 2012-07-31 | 2013-07-31 | - | - | 2025-07-14 |
| Specimen Repository for HIV Immunopathogenesis | NCT03579381 | AIDS Healthcare Foundation | user2@example.com | None | 2017-07-31 | 2019-01-25 | 2020-01-25 | - | - | 2025-07-14 |
| Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection | NCT03399903 | AIDS Healthcare Foundation | user2@example.com | None | 2017-05-01 | 2019-03-22 | 2020-03-22 | - | - | 2025-07-14 |